Literature DB >> 8323539

A missense mutation (Trp 26-->Arg) in exon 3 of the apolipoprotein CII gene in a patient with apolipoprotein CII deficiency (apo CII-Wakayama).

H Inadera1, A Hibino, J Kobayashi, T Kanzaki, K Shirai, S Yukawa, Y Saito, S Yoshida.   

Abstract

We studied the molecular basis of a case of apolipoprotein CII (apo CII) deficiency with a history of familial consanguinity. DNA sequence analysis of the apo CII gene from the patient revealed a homozygous nucleotide change: a T-->C transition for codon 26 (TGG) at nucleotide 2967 of the third exon resulting in a Trp26-->Arg substitution. His mother was heterozygous of the same mutation and showed half the value of normal apo CII/apo CIII. Analysis of his brother who showed the normal apo CII concentration revealed no mutation at the same place. These results suggested that this missense mutation could be the cause of apo CII deficiency in this kindred.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8323539     DOI: 10.1006/bbrc.1993.1749

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

2.  Apolipoprotein C-II Mimetic Peptide Promotes the Plasma Clearance of Triglyceride-Rich Lipid Emulsion and the Incorporation of Fatty Acids into Peripheral Tissues of Mice.

Authors:  Tomohiro Komatsu; Toshihiro Sakurai; Anna Wolska; Marcelo J Amar; Akiko Sakurai; Boris L Vaisman; Denis Sviridov; Stephen Demosky; Milton Pryor; Katsunori Ikewaki; Alan T Remaley
Journal:  J Nutr Metab       Date:  2019-02-03

3.  A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis.

Authors:  Jingjing Jiang; Yuhui Wang; Yan Ling; Abudurexiti Kayoumu; George Liu; Xin Gao
Journal:  Lipids Health Dis       Date:  2016-01-16       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.